Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc
CA 1340914 C · Owner: Goudsmit, Jaap · Inventors: Goudsmit, Jaap; Meloen, Robert Hans
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to oligopeptides having utility in diagnosis of, or vaccination against AIDS and ARC, and to antibodies raised against such oligopeptides. The oligopeptides have a length of 8 to 17 amino acids. The amino acid sequence corresponds to a sequence occurring in the V3 region of gp120 and comprises the .beta.-turn sequence GPG(R) at the positions 312-314 (315), or a variant .beta.-turn sequence, and flanking sequences of at least one and preferably at least two amino acids on both sides of the .beta.-turn sequence.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted February 29, 2000. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 28, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.